How many UK clinics currently offer ChondroFiller injection?

Finding a UK clinic that offers ChondroFiller injection is straightforward — as of mid-2026, only two clinic groups provide the treatment as an outpatient injection: one based in London, the other operating sites in the East Midlands. That small number is not a cause for concern; it reflects how recently the injectable pathway was introduced in the UK, rather than any uncertainty about the treatment itself.

Because the provider pool is so concentrated, the practical task shifts quickly from discovery to evaluation. Once a patient knows where the two options are, the more important questions become how each provider compares — in expertise, imaging infrastructure, and the range of pathways they can offer — and whether the patient is a suitable candidate for the injection route at all.

Both clinic groups accept self-referrals: no GP letter is needed to book an initial assessment. ChondroFiller sits entirely outside the NHS, with no NICE appraisal and no commissioned pathway on the public system, so all access is privately funded from the outset.

Who the injection pathway is designed for

The injection pathway is designed for a specific type of cartilage damage: a focal, contained lesion graded III or IV on the ICRS scale — where the articular surface has broken down in a defined area rather than across the joint as a whole. ChondroFiller works through acellular matrix-induced chondrogenesis, placing a collagen scaffold that recruits the patient's own repair cells into the defect site. That mechanism depends on having a localised target; it is not indicated for the diffuse joint-surface loss seen in widespread osteoarthritis.

Patients whose imaging shows broader degeneration, or whose defect is too large or load-bearing for an injectable approach, will typically be directed toward a surgical alternative — usually an arthroscopic procedure — rather than the outpatient injection pathway. This distinction matters when comparing providers: not every clinic offering ChondroFiller injection can also offer or refer to the surgical escalation route, and knowing which pathway fits your presentation determines which clinic comparison is actually relevant to you.

An initial assessment — covering imaging review and symptom history — establishes candidacy before any treatment commitment. This step is genuinely useful: it narrows the decision to the options that suit your joint, rather than those available in general.

What a ChondroFiller outpatient appointment involves

The appointment itself is an outpatient procedure, carried out under local anaesthesia in a clinic setting — no theatre admission, no general anaesthetic, and no overnight stay. ChondroFiller is placed as a single injection under real-time ultrasound guidance, which allows the clinician to position the collagen scaffold accurately within the defect rather than relying on surface landmarks alone.

That imaging step is not incidental. Without dedicated ultrasound capability, safe and precise placement is not possible, so the presence of in-clinic imaging equipment is a practical question worth asking any provider at first contact.

Depending on the size and location of the defect, a course may involve one, two, or three units of implant — most focal lesions require only one. A complete course typically encompasses the initial consultation, imaging guidance during the procedure, the implant itself, intravenous antibiotic cover, and a follow-up appointment around six weeks later. Inclusions are not identical across providers, however, so patients should ask explicitly what a quoted price covers before making any comparison.

Useful questions to raise at first contact include: Is ultrasound guidance included and performed by the treating clinician? How many units are likely to be needed based on my imaging? What does the quoted fee cover from consultation through to follow-up?

Three criteria worth comparing between UK providers

No independent, head-to-head comparison of the two UK clinic groups on outcomes has been published, so the decision rests on practical criteria rather than comparative data. Three are worth examining before booking.

1. Familiarity with the delivery technique

ChondroFiller is not a standard joint injection; its delivery requires specific training in placing an in-situ-gelling scaffold accurately under imaging guidance. Ask any provider how many procedures the team has performed and whether they hold relevant accreditation. One clinic group holds ICRS International Teaching Centre of Excellence status, which is a verifiable credential; the other offers consultant-led regional outpatient access. Both facts are worth confirming directly rather than assumed from a website.

2. Imaging infrastructure

Ultrasound or fluoroscopic guidance is required for safe, accurate placement. Section 3 noted this, but at provider-comparison stage the practical question is whether imaging is part of the standard procedure or a billable addition. Confirm this before accepting a quote.

3. Service scope — escalation pathway and geographic access

If assessment shows your defect is unsuitable for injection, can the same clinic progress you to an arthroscopic route, or would you need to start again elsewhere? The ability to offer both pathways without a cross-referral gap is a material factor. Geography is equally practical: one clinic group is London-based; the other operates in the East Midlands. Factor travel time and any repeat-visit requirements — follow-up is typically at six weeks — into the comparison alongside clinical criteria.

Cost and what your quote should cover

Guide costs for ChondroFiller follow a tiered, volume-based structure determined by how many units the defect requires. One clinic group publishes its tariff: £3,000 for a single unit, £5,500 for two, and £8,000 for three. Treat these as a published starting reference — the other UK clinic group does not publish its pricing online, so a direct quote is needed before any meaningful comparison can be made.

Most focal lesions are treated with one unit, placing the majority of patients at the lower end of that range. Multi-compartment or larger defects may require two or three.

The cost sits substantially above a standard joint injection because ChondroFiller is a CE-marked Class III medical device, imported from German manufacturer Meidrix Biomedicals GmbH under a separate prescription raised for each individual patient. That per-patient import and prescription process carries regulatory overhead that a straightforward pharmaceutical injection does not — the price reflects that supply chain, not clinic mark-up.

When requesting a quote, confirm that all the inclusions described in the previous section are within the quoted figure; they are not uniform across providers. Get that breakdown in writing. Comparing headline prices without knowing what each covers is not a reliable basis for a decision.

Private medical insurance and ChondroFiller

PMI does not routinely cover ChondroFiller, but some policies have been approved — most often with Bupa, Aviva, and WPA. Policy terms vary considerably, and an approval for one patient does not predict approval for another, even with the same insurer. The only reliable step is to obtain written pre-authorisation before treatment begins; proceeding without it removes any realistic prospect of reimbursement.

When approaching your insurer, ask your clinic which CCSD codes apply. Claims for cartilage regeneration with a collagen scaffold are typically associated with W3111; W8500 is linked to arthroscopic procedures. Your clinic can confirm which codes are relevant and help frame the pre-authorisation request accurately. Do not assume from a general policy description that a Class III medical device is covered — ask specifically about ChondroFiller.

If you are self-funding, budget across the full episode: consultation, the procedure, and the six-week follow-up at minimum.

With only two UK provider groups, the practical decision ultimately rests on three converging factors that earlier sections have laid out: which clinic is accessible to you geographically, how soon an assessment appointment is available, and whether that clinic can offer the full pathway — outpatient injection now, arthroscopic escalation if the defect warrants it — without requiring a separate referral elsewhere. Search MSK lists ChondroFiller specialists across the UK with filters for region and specialty, so you can identify the right starting point for your situation without having to contact every clinic individually.